Psychological responses and coping strategies among patients with malignant melanoma: A systematic review of the literature

Archives of Dermatology

Volumn 145, Issue 12, 2009, Pages 1415-1427

  Kasparian, Nadine A ^a,c   McLoone, Jordana K ^b,c   Butow, Phyllis N ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; CINAHL; COPING BEHAVIOR; DEMOGRAPHY; DISTRESS SYNDROME; EDUCATIONAL STATUS; EMOTIONAL STRESS; FAMILY HISTORY; HEALTH BELIEF; HUMAN; MEDLINE; MELANOMA; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; PSYCINFO; RELIGION; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX; SOCIAL ASPECT; SOCIAL SUPPORT; SYSTEMATIC REVIEW;

ADAPTATION, PSYCHOLOGICAL; FEMALE; HUMANS; MALE; MELANOMA; RISK FACTORS; SKIN NEOPLASMS; STRESS, PSYCHOLOGICAL;

EID: 73149105166     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.308     Document Type: Review

References (67)

1. Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psycho-oncology. 2001;10(1): 19-28.
2. Dirksen SR. Perceived well-being in malignant melanoma survivors. Oncol Nurs Forum. 1989;16(3):353-358.
3. Cassileth BR, Lusk EJ, Tenaglia AN. Patients' perceptions of the cosmetic impact of melanoma resection. Plast Reconstr Surg. 1983;71(1):73-75.
4. Kneier AW. Coping with melanoma: ten strategies that promote psychological adjustment. Surg Clin North Am. 2003;83(2):417-430.
5. de Braud F, Khayat D, Kroon BB, Valdagni R, Bruzzi P, Cascinelli N. Malignant melanoma. Crit Rev Oncol Hematol. 2003;47(1):35-63.
6. Ries L, Eisner M, Kosary C, et al. SEER Cancer Statistics Review, 1975-2002. Bethesda, MD: National Cancer Institute; 2005.
7. Lamb LA, Halpern A, Hwu W-J. Diagnosis and management of stage I/II melanoma. Semin Oncol Nurs. 2003;19(1):22-31.
8. Söllner W, Zingg-Schir M, Rumpold G, Mairinger G, Fritsch P. Need for supportive counseling: the professionals' versus the patients' perspective: a survey in a representative sample of 236 melanoma patients. Psychother Psychosom. 1998; 67(2):94-104.
9. Fawzy FI, Cousins N, Fawzy NW, Kemeny ME, Elashoff R, Morton D. A structured psychiatric intervention for cancer patients, I: changes over time and methods of coping in affect of disturbance. Arch Gen Psychiatry. 1990;47(8):720-725.
10. Holland JC, Passik S, Kash KM, et al. The role of religious and spiritual beliefs in coping with malignant melanoma. Psycho-oncology. 1999;8(1):14-26.
11. Missiha SB, Solish N, From L. Characterizing anxiety in melanoma patients. J Cutan Med Surg. 2003;7(6):443-448.
12. Lichtenthal WG, Cruess DG, Clark VL, Ming ME. Investment in body image among patients diagnosed with or at risk for malignant melanoma. Body Image. 2005; 2(1):41-51.
13. National Breast Cancer Centre and National Cancer Control Initiative. Clinical Practice Guidelines for the Psychosocial Care Of Adults With Cancer. Camperdown NSW, Australia: National Breast Cancer Centre; 2003.
14. Cassileth BR, Lusk EJ, Tenaglia AN. A psychological comparison of patients with malignant melanoma and other dermatologic disorders. J Am Acad Dermatol. 1982;7(6):742-746.
15. Baider L, Perry S, Sison A, et al. The role of psychological variables in a group of melanoma patients: an Israeli sample. Psychosomatics. 1997;38(1):45-53.
16. Sigurdardóttir V, Bolund C, Brandberg Y, Sullivan M. The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique. Qual Life Res. 1993;2(3):193-203.
17. Brandberg Y, Mansson-Brahme E, Ringborg U, Sjoden P. Psychological reactions in patients with malignant melanoma. Eur J Cancer. 1995;31A(2):157-162.
18. Trask PC, Paterson AG, Hayasaka S, Dunn RL, Riba M, Johnson T. Psychosocial characteristics of individuals with non-stage IV melanoma. J Clin Oncol. 2001; 19(11):2844-2850.
19. Gibertini M, Reintgen DS, Baile WF. Psychosocial aspects of melanoma. Ann Plast Surg. 1992;28(1):17-21.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000.
21. Kelly B, Raphael B, Smithers M, et al. Psychological responses to malignant melanoma: an investigation of traumatic stress reactions to life-threatening illness. Gen Hosp Psychiatry. 1995;17(2):126-134.
22. Bergenmar M, Nilsson B, Hansson J, Brandberg Y. Anxiety and depressive symptoms measured by the Hospital Anxiety and Depression Scale as predictors of time to recurrence in localized cutaneous melanoma. Acta Oncol. 2004;43(2): 161-168.
23. Brandberg Y, Bergenmar M, Michelson H, Mansson-Brahme E, Sjoden PO. Six-month follow-up of effects of an information programme for patients with malignant melanoma. Patient Educ Couns. 1996;28(2):201-208.
24. Brandberg Y, Bolund C, Sigurdardóttir V, Sjoden P-O, Sullivan M. Anxiety and depressive symptoms at different stages of malignant melanoma. Psycho-oncology. 1992;1(2):71-78.
25. Brandberg Y, Kock E, Oskar K, af Trampe E, Seregard S. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study. Eye. 2000; 14(pt 6):839-846.
26. Brandberg Y, Bergenmar M, Bolund C, Månsson-Brahme E, Ringborg U, Sjødén PO. Psychological effects of participation in a prevention programme for individuals with increased risk for malignant melanoma. Eur J Cancer. 1992;28A (8-9):1334-1338.
27. Horowitz M, Wilner N, Alvarez W. The Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979;41(3):209-218.
28. Smith MY, Redd WH, Peyser C, Vogl D. Post-traumatic stress disorder in cancer: a review. Psycho-oncology. 1999;8(6):521-537.
29. Baughan CA, Hall VL, Leppard BJ, Perkins PJ. Follow-up in stage I cutaneous malignant melanoma: an audit. Clin Oncol. 1993;5(3):174-180.
30. Kasparian NA, Meiser B, Butow PN, Simpson JM, Mann GJ. Predictors of psychological distress among individuals with a strong family history of malignant melanoma. Clin Genet. 2008;73(2):121-131.
31. Bishop DT, Demenais F, Goldstein A, et al; Melanoma Genetics Consortium. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst. 2002;94(12):894-903.
32. Riedijk S, de Snoo F, van Dijk S, et al. Hereditary melanoma and predictive genetic testing: why not? Psycho-oncology. 2005;14:738-745.
33. Baider L, Russak SM, Perry S, et al. The role of religious and spiritual beliefs in coping with malignant melanoma: an Israeli sample. Psycho-oncology. 1999; 8(1):27-35.
34. Brown J, Brown R, Miller R, et al. Coping with metastatic melanoma: the last year of life. Psycho-oncology. 2000;9:283-292.
35. Brown JE, King MT, Butow PN, Dunn SM, Coates AS. Patterns over time in quality of life, coping and psychological adjustment in late stage melanoma patients: an application of multilevel models. Qual Life Res. 2000;9(1):75-85.
36. Brown JE, Butow PN, Culjak G, Coates AS, Dunn SM. Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma. Br J Cancer. 2000;83(11):1448-1453.
37. Butow PN, Coates AS, Dunn SM. Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol. 1999;17(7):2256-2263.
38. Hamama-Raz Y, Solomon Z. Psychological adjustment of melanoma survivors: the contribution of hardiness, attachment, and cognitive appraisal. J Individual Differences. 2006;27(3):172-182.
39. Hamama-Raz Y, Solomon Z, Schachter J, Azizi E. Objective and subjective stressors and the psychological adjustment of melanoma survivors. Psycho-oncology. 2007;16:287-294.
40. Lehto US, Ojanen M, Kellokumpu-Lehtinen P. Predictors of quality of life in newly diagnosed melanoma and breast cancer patients. Ann Oncol. 2005;16(5):805-816.
41. Reimer J, Esser J, Fleiss A, et al. Quality of life in patients with malignant choroidal melanoma after radiotherapy. Graefes Arch Clin Exp Ophthalmol. 2003; 241(5):371-377.
42. Söllner W, Zschocke I, Zingg-Schir M, et al. Interactive patterns of social support and individual coping strategies in melanoma patients and their correlations with adjustment to illness. Psychosom. 1999;40(3):239-250.
43. Trask PC, Griffith KA. The identification of empirically derived cancer patient subgroups using psychosocial variables. J Psychosom Res. 2004;57(3):287-295.
44. Vurnek M, Buljan M, Situm M. Psychological status and coping with illness in patients with malignant melanoma. Coll Antropol. 2007;31(S1)(suppl 1): 53-56.
45. Fawzy NW. A psychoeducational nursing intervention to enhance coping and affective state in newly diagnosed malignant melanoma patients. Cancer Nurs. 1995; 18(6):427-438.
46. Folkman S, Lazarus R, Gruen R, DeLongis A. Appraisal, coping, health status, and psychological symptoms. J Pers Soc Psychol. 1986;50(3):571-579.
47. Levy S, Heiden L. Personality and social factors in cancer outcome. In: Friedman H, ed. Personality and Disease. New York: John Wiley & Sons; 1990:254-279.
48. Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response. Soc Sci Med. 1985;20(8):833-840.
49. Lichtenthal WG, Cruess DG, Schuchter LM, Ming ME. Psychosocial factors related to the correspondence of recipient and provider perceptions of social support among patients diagnosed with or at risk for malignant melanoma. J Health Psychol. 2003;8(6):705-719.
50. Devine D, Parker PA, Fouladi RT, Cohen L. The association between social support, intrusive thoughts, avoidance, and adjustment following an experimental cancer treatment. Psycho-oncology. 2003;12(5):453-462.
51. Holland JC, Kash KM, Passik S, et al. A brief spiritual beliefs inventory for use in quality of life research in life-threatening illness. Psycho-oncology. 1998;7 (6):460-469.
52. Bonevski B, Sanson-Fisher R, Hersey P, Paul C, Foot G. Assessing the perceived needs of patients attending an outpatient melanoma clinic. J Psychosoc Oncol. 1999;17(3-4):101-118.
53. Söllner W, Zingg-Schir M, Rumpold G, Fritsch P. Attitude toward alternative therapy, compliance with standard treatment, and need for emotional support in patients with melanoma. Arch Dermatol. 1997;133(3):316-321.
54. Fawzy FI, Canada AL, Fawzy NW. Malignant melanoma: effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up. Arch Gen Psychiatry. 2003;60(1):100-103.
55. Fawzy FI. A short-term psychoeducational intervention for patients newly diagnosed with cancer. Support Care Cancer. 1995;3(4):235-238.
56. Söllner W, Gross R, Maislinger S. Psychotherapeutic interventions in melanoma patients. Recent Results Cancer Res. 2002;160:362-369.
57. Robinson JK, Dellavalle R, Bigby M, Callen J. Systematic reviews: grading recommendations and evidence quality. Arch Dermatol. 2008;144(1):97-99.
58. Institute of Medicine. 10-Point plan for more comprehensive cancer care. CA Cancer J Clin. 2008;58:67-68.
59. Australian Cancer Network. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Canberra, Australia: National Health and Medical Research Council; 2008.
60. Weiss D, Marmar C. Impact of Event Scale-Revised. In: Wilson J, Keane T, eds. Assessing Psychological Trauma and PTSD. New York: Guilford; 1997:399-428.
61. Fawzy FI, Kemeny ME, Fawzy NW, et al. A structured psychiatric intervention for cancer patients; II: changes over time in immunological measures. Arch Gen Psychiatry. 1990;47(8):729-735.
62. FawzyI F, Fawzy N, Hyun C, et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry. 1993;50(9):681-689.
63. Boesen EH, Ross L, Frederiksen K, et al. Psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study. J Clin Oncol. 2005; 23(6):1270-1277.
64. Bares CB, Trask PC, Schwartz SM. An exercise in cost-effectiveness analysis: treating emotional distress in melanoma patients. J Clin Psychol Med Settings. 2002;9(3):193-200.
65. Meyer TJ, Mark M. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol. 1995;14 (2):101-108.
66. Gill D, Hatcher S. Antidepressants for depression in people with physical illness. Cochrane Database Syst Rev. 2000;(3):CD001312.
67. Spiegel D. Health caring: psychosocial support for patients with cancer. Cancer. 1994;74(4)(suppl):1453-1457.